Skip to main content

Long-term risk of autoimmune diseases after mRNA-based SARS-CoV-2 vaccination in a Korean, nationwide, population-base cohort study

Journal: Nat Commun
Lead Author: Jung, S et al.
Original date of publication: 07/23/2024
Link: https://pubmed.ncbi.nlm.nih.gov/39039113/

Summary Context

This study outlines how public data in South Korea shows that mRNA-based vaccination increases lupus diagnosis

Comments

This article is copyrighted by Health Freedom Defense Fund, Inc.
Visit our Re-post guidelines

South Korean study of 9 million health records shows an increase in lupus erythematosus with a 1.16 increase risk in mRNA vaccinated people.

Abstract or Results, Key Passages

“We report that the risk of developing most AI-CTDs did not increase following mRNA vaccination, except for systemic lupus erythematosus with a 1.16-fold risk in vaccinated individuals relative to controls. Comparable results were reported in the stratified analyses for age, sex, mRNA vaccine type, and prior history of non-mRNA vaccination. “


Keywords: adverse eventscovid vaccinationlupusmRNAPfizer
Full Author List: Seung-Won Jung, Jae Joon Jeon, You Hyun Kim, Sung Jay Choe & Solam Lee